The presence of enterovirus, adenovirus, and parvovirus B19 in myocardial tissue samples from autopsies: An evaluation of their frequencies in deceased individuals with myocarditis and in non-inflamed control hearts

Forensic Science, Medicine, and Pathology

Volumn 10, Issue 3, 2014, Pages 344-350

  Nielsen, Trine Skov ^a,b   Hansen, Jakob ^b   Nielsen, Lars Peter ^d   Baandrup, Ulrik Thorngren ^a   Banner, Jytte ^b,c  

^a AALBORG UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

Adenovirus; Enterovirus; Forensic medicine; Myocarditis; Parvovirus B19; PCR

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS ANTIBODY; VIRUS DNA;

ADENOVIRIDAE; ADENOVIRUS INFECTION; ADOLESCENT; ADULT; AGED; AUTOPSY; BLOOD; CASE CONTROL STUDY; CAUSE OF DEATH; CHILD; ENTEROVIRUS; ENTEROVIRUS INFECTION; FEMALE; FORENSIC GENETICS; GENETICS; HEART; HEART MUSCLE; HUMAN; HUMAN PARVOVIRUS B19; IMMUNOLOGY; INFANT; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; MORTALITY; MYOCARDITIS; NEWBORN; PARVOVIRUS INFECTION; PATHOLOGY; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PROCEDURES; RISK FACTOR; SEROLOGY; VIROLOGY; YOUNG ADULT;

ADENOVIRIDAE; ADENOVIRIDAE INFECTIONS; ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; AUTOPSY; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DNA, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; FORENSIC GENETICS; HEART; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MYOCARDITIS; MYOCARDIUM; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; RISK FACTORS; SEROLOGIC TESTS; YOUNG ADULT;

EID: 84905715700     PISSN: 1547769X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12024-014-9570-7     Document Type: Article

References (49)

1. Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust. 2004;180(3): 110-2.
2. Langlois NE. Sudden adult death. Forensic Sci Med Pathol. 2009;5(3): 210-32.
3. Diaz FJ, Loewe C, Jackson A. Death caused by myocarditis in Wayne County, Michigan: a 9-year retrospective study. Am J Forensic Med Pathol. 2006;27(4): 300-3.
4. Burke AP, Saenger J, Mullick F, Virmani R. Hypersensitivity myocarditis. Arch Pathol Lab Med. 1991;115(8): 764-9.
5. Courand PY, Croisille P, Khouatra C, Cottin V, Kirkorian G, Bonnefoy E. Churg-Strauss syndrome presenting with acute myocarditis and cardiogenic shock. Heart Lung Circ. 2012;21(3): 178-81.
6. De BD, Serroni N, Campanella D, Olivieri L, Ferri F, Carano A, et al. Update on the adverse effects of clozapine: focus on myocarditis. Curr Drug Saf. 2012;7(1): 55-62.
7. Nicklin A, Byard RW. Lethal manifestations of systemic lupus erythematosus in a forensic context. J Forensic Sci. 2011;56(2): 423-8.
8. Phillips K, Luk A, Soor GS, Abraham JR, Leong S, Butany J. Cocaine cardiotoxicity: a review of the pathophysiology, pathology, and treatment options. Am J Cardiovasc Drugs. 2009;9(3): 177-96.
9. Pilgrim JL, Woodford N, Drummer OH. Cocaine in sudden and unexpected death: a review of 49 post-mortem cases. Forensic Sci Int. 2013;227(1-3): 52-9.
10. Kawai C, Matsumori A. Dilated cardiomyopathy update: infectious-immune theory revisited. Heart Fail Rev. 2013;18(6): 703-14.
11. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59(9): 779-92.
12. Yajima T, Knowlton KU. Viral myocarditis: from the perspective of the virus. Circulation. 2009;119(19): 2615-24.
13. Byard RW. Forensic pathology and problems in determining cause of death. Forensic Sci Med Pathol. 2008;4(2): 73-4.
14. Casali MB, Lazzaro A, Gentile G, Blandino A, Ronchi E, Zoja R. Forensic grading of myocarditis: an experimental contribution to the distinction between lethal myocarditis and incidental myocarditis. Forensic Sci Int. 2012;223(1-3): 78-86.
15. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33): 2636-48.
16. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42(3): 466-72.
17. Gaaloul I, Riabi S, Harrath R, Evans M, Salem NH, Mlayeh S, et al. Sudden unexpected death related to enterovirus myocarditis: histopathology, immunohistochemistry and molecular pathology diagnosis at post-mortem. BMC Infect Dis. 2012;12: 212.
18. Guarner J, Bhatnagar J, Shieh WJ, Nolte KB, Klein D, Gookin MS, et al. Histopathologic, immunohistochemical, and polymerase chain reaction assays in the study of cases with fatal sporadic myocarditis. Hum Pathol. 2007;38(9): 1412-9.
19. Hufnagel G, Pankuweit S, Richter A, Schonian U, Maisch B. The European Study of Epidemiology and Treatment of Cardiac Inflammatory Diseases (ESETCID). First epidemiological results. Herz. 2000;25(3): 279-85.
20. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, et al. Predictors of outcome in patients with suspected myocarditis. Circulation. 2008;118(6): 639-48.
21. Koepsell SA, Anderson DR, Radio SJ. Parvovirus B19 is a bystander in adult myocarditis. Cardiovasc Pathol. 2012;21(6): 476-81.
22. Kyto V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, Saraste A, et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis. 2005;40(5): 683-8.
23. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, et al. Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation. 2006;114(15): 1581-90.
24. Martin AB, Webber S, Fricker FJ, Jaffe R, Demmler G, Kearney D, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90(1): 330-9.
25. Schenk T, Enders M, Pollak S, Hahn R, Huzly D. High prevalence of human parvovirus B19 DNA in myocardial autopsy samples from subjects without myocarditis or dilative cardiomyopathy. J Clin Microbiol. 2009;47(1): 106-10.
26. Bultmann BD, Klingel K, Sotlar K, Bock CT, Baba HA, Sauter M, et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol. 2003;34(1): 92-5.
27. Pankuweit S, Klingel K. Viral myocarditis: from experimental models to molecular diagnosis in patients. Heart Fail Rev. 2013;18(6): 683-702.
28. Soderlund-Venermo M, Hokynar K, Nieminen J, Rautakorpi H, Hedman K. Persistence of human parvovirus B19 in human tissues. Pathol Biol (Paris). 2002;50(5): 307-16.
29. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997;53(3): 229-32.
30. Soderlund M, von ER, Haapasaari J, Kiistala U, Kiviluoto O, Hedman K. Persistence of parvovirus B19 DNA in synovial membranes of young patients with and without chronic arthropathy. Lancet. 1997;349(9058): 1063-5.
31. Modrow S, Dorsch S. Antibody responses in parvovirus B19 infected patients. Pathol Biol (Paris). 2002;50(5): 326-31.
32. Aretz HT. Myocarditis: the Dallas criteria. Hum Pathol. 1987;18(6): 619-24.
33. Loewe R. RNA-Isolation aus FFPE-Gewebe: Säulchen- und Bead-basierte Methoden. Laborwelt. 2011;12(5): 38-9.
34. Heim A, Ebnet C, Harste G, Pring-Akerblom P. Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003;70(2): 228-39.
35. Baylis SA, Shah N, Minor PD. Evaluation of different assays for the detection of parvovirus B19 DNA in human plasma. J Virol Methods. 2004;121(1): 7-16.
36. Rotbart HA. Enzymatic RNA amplification of the enteroviruses. J Clin Microbiol. 1990;28(3): 438-42.
37. Mohamed N, Elfaitouri A, Fohlman J, Friman G, Blomberg J. A sensitive and quantitative single-tube real-time reverse transcriptase-PCR for detection of enteroviral RNA. J Clin Virol. 2004;30(2): 150-6.
38. Hansen J, Corydon TJ, Palmfeldt J, Durr A, Fontaine B, Nielsen MN, et al. Decreased expression of the mitochondrial matrix proteases Lon and ClpP in cells from a patient with hereditary spastic paraplegia (SPG13). Neuroscience. 2008;153(2): 474-82.
39. Donoso MO, Meyer R, Prosch S, Nitsche A, Leitmeyer K, Kallies R, et al. High prevalence of cardiotropic viruses in myocardial tissue from explanted hearts of heart transplant recipients and heart donors: a 3-year retrospective study from a German patients' pool. J Heart Lung Transplant. 2005;24(10): 1632-8.
40. Kuethe F, Lindner J, Matschke K, Wenzel JJ, Norja P, Ploetze K, et al. Prevalence of parvovirus B19 and human bocavirus DNA in the heart of patients with no evidence of dilated cardiomyopathy or myocarditis. Clin Infect Dis. 2009;49(11): 1660-6.
41. Wang X, Zhang G, Liu F, Han M, Xu D, Zang Y. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization. J Clin Virol. 2004;31(1): 20-4.
42. Rohrer C, Gartner B, Sauerbrei A, Bohm S, Hottentrager B, Raab U, et al. Seroprevalence of parvovirus B19 in the German population. Epidemiol Infect. 2008;136(11): 1564-75.
43. Mahfoud F, Gartner B, Kindermann M, Ukena C, Gadomski K, Klingel K, et al. Virus serology in patients with suspected myocarditis: utility or futility? Eur Heart J. 2011;32(7): 897-903.
44. Lamparter S, Schoppet M, Pankuweit S, Maisch B. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol. 2003;34(7): 725-8.
45. Why HJ, Meany BT, Richardson PJ, Olsen EG, Bowles NE, Cunningham L, et al. Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation. 1994;89(6): 2582-9.
46. Mizuno T, Nagamura H, Iwamoto KS, Ito T, Fukuhara T, Tokunaga M, et al. RNA from decades-old archival tissue blocks for retrospective studies. Diagn Mol Pathol. 1998;7(4): 202-8.
47. Farragher SM, Tanney A, Kennedy RD, Paul HD. RNA expression analysis from formalin fixed paraffin embedded tissues. Histochem Cell Biol. 2008;130(3): 435-45.
48. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5): 269-75.
49. Mintz L, Drew WL. Relation of culture site to the recovery of nonpolio enteroviruses. Am J Clin Pathol. 1980;74(3): 324-6.